FDA inspection
KBI Biopharma, Inc.: FDA inspection ending Oct 9, 2009
FDA inspection 625271 · No Action Indicated (NAI) · Durham, NC
Key facts
| Inspection ID | 625271 |
|---|---|
| Firm | KBI Biopharma, Inc. |
| FEI number | 3004638264 |
| Address | 1101 Hamlin Rd |
| City | Durham |
| State | NC |
| ZIP | 27704 |
| Country | United States |
| Fiscal year | 2010 |
| Inspection end date | Oct 9, 2009 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data